Latest Articles

  • Idiopathic thrombocytopenic purpura: Guidance amid uncertainty
    Alan Lichtin, MD
    Cleveland Clinic Journal of Medicine November 1998, 65 (10) 510-514;

    A panel of experts has issued clinical guidelines for treating thrombocytopenic purpura, but points out that we lack solid evidence from randomized trials.

  • Bipolar disorder: Current treatments and new strategies
    Gary S. Sachs, MD and Victoria E. Cosgrove, BA
    Cleveland Clinic Journal of Medicine November 1998, 65 (10 suppl 1) SI-31-SI-38;
  • Panel discussions
    Harold H. Morris, MD, Edward C. Covington, MD, Gary S. Sachs, MD and Jonathan R.T. Davidson, MD
    Cleveland Clinic Journal of Medicine November 1998, 65 (10 suppl 1) SI-45-SI-47;
  • Avoiding adverse drug effects in elderly patients
    Rosanne M. Leipzig, MD, PhD
    Cleveland Clinic Journal of Medicine October 1998, 65 (9) 470-478;

    A working knowledge of pharmacokinetics and pharmacodynamics pays off in avoiding adverse drug effects in vulnerable patients.

  • Asymptomatic hypercalcemia (May 1998)
    M. Sarshar, MD
    Cleveland Clinic Journal of Medicine October 1998, 65 (9) 500;
  • The current role of amiodarone in patients with congestive heart failure
    David Bello, MD and Barry M. Massie, MD
    Cleveland Clinic Journal of Medicine October 1998, 65 (9) 479-489;

    Amiodarone is the antiarrhythmic agent of choice for patients with congestive heart failure, but its clinical benefit remains unproved.

  • Dear Colleague
    John D. Clough, MD
    Cleveland Clinic Journal of Medicine October 1998, 65 (9) 450;
  • Addressing coronary heart disease risk in women
    Nanette K. Wenger, MD
    Cleveland Clinic Journal of Medicine October 1998, 65 (9) 464-469;

    Coronary heart disease is common and serious in women, and deserves more attention.

  • The keyhole or the manhole? What internists need to know about minimally invasive CABG
    Joseph Sabik, MD
    Cleveland Clinic Journal of Medicine October 1998, 65 (9) 454-456;

    Thousands of patients have undergone minimally invasive coronary artery bypass surgery, but some have contraindications to it. With an illustration showing the two major minimally invasive techniques.

  • The prostate cancer screening controversy in perspective
    Kenneth W. Vaughn, MD
    Cleveland Clinic Journal of Medicine October 1998, 65 (9) 459-462;

    The value of screening for prostate cancer is not yet proven, hut the magnitude of the problem argues for action.

Pages